Optimer Pharmaceuticals, Inc. (OPTR)

[oldberkeley]

OPTR: Bought in yesterday and mid-afternoon today, very surprised by the end-of-day drastic drop.

The earnings report looks fine, they're in the green, looks like they're getting stuff together in prep for approval.

My only concern is the recurrence wording on the label, hopefully they'll work out a satisfactory compromise with the FDA.

If I get the chance tomorrow, I'll average-down under $12.

Best of luck to all.